1 Introduction
The novel coronavirus disease (COVID‐19), which is associated with significant morbidity and medical complications induced by SARS- CoV-2, has rapidly spread sparking alarm worldwide.1,2 In June 2020 WHO declared COVID-19 as global pandemic which has made many countries to shut down their borders3. Asthma has become the most common chronic respiratory disease in children4-6. As is well known to all for many decades, respiratory infections trigger asthma exacerbations7. Studies had reported that patients with asthma would experience increased asthma-associated morbidity because of the respiratory virus SARS-CoV-2 infection, based on experience with other respiratory viral infections8,9. However, some studies suggested that there was no apparent increase in asthma related morbidity in children with asthma10, it is even possible that due to reduced exposures due to confinement, such children may have improved outcomes11.
The main objective of this study was to identify how is the asthma in children during the COVID-19 pandemic controlled compared with the time before it.